by Henrik Frederiksen, and Kai Schmidt

Slides:

Advertisements

Similar presentations

RNA interference in biology and disease by Carol A. Sledz, and Bryan R. G. Williams Blood Volume 106(3): August 1, 2005 ©2005 by American Society.

Advertisements

Idiopathic Thrombocytopenic Purpura Clinical Features.

Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases by Porcia T. Bradford, Susan S. Devesa, William F. Anderson,

Combination immunosuppressant therapy for patients with chronic refractory immune thrombocytopenic purpura by Donald M. Arnold, Ishac Nazi, Aurelio Santos,

Dosing lepirudin in patients with heparin-induced thrombocytopenia and normal or impaired renal function: a single-center experience with 68 patients by.

Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Bleeding Risk and Natural History of Idiopathic.

Who is the best donor for a related HLA haplotype-mismatched transplant? by Yu Wang, Ying-Jun Chang, Lan-Ping Xu, Kai-Yan Liu, Dai-Hong Liu, Xiao-Hui Zhang,

Individuals’ bleeding time measurements (in minutes) plotted against their respective platelet counts. As the straight vertical and diagonal lines show,

The influence of high-altitude living on body iron

by Robert F. Todd, Scott D. Gitlin, Linda J. Burns, and

MBL: mostly benign lymphocytes, but…

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

Rituximab efficacy and safety in adult splenectomy candidates with chronic immune thrombocytopenic purpura: results of a prospective multicenter phase.

A Randomized Trial Of Daily Prednisone Versus Pulsed Dexamethasone In Treatment Naïve Patients With Idiopathic Thrombocytopenic Purpura by Johannes Matschke,

Triple play of H pylori in ITP

Platelet Antibody Testing in Idiopathic Thrombocytopenic Purpura

Gupta V, Tallman MS, Weisdorf DJ

A Clinical Evaluation of the International Lymphoma Study Group Classification of Non-Hodgkin's Lymphoma Blood Volume 89(11): June 1, 1997 ©1997.

Coagulation factors IX through XIII and the risk of future venous thrombosis: the Longitudinal Investigation of Thromboembolism Etiology by Mary Cushman,

Haploidentical vs identical-sibling transplant for AML in remission: a multicenter, prospective study by Yu Wang, Qi-Fa Liu, Lan-Ping Xu, Kai-Yan Liu,

Relative contribution of CYP2C9 and VKORC1 genotypes and early INR response to the prediction of warfarin sensitivity during initiation of therapy by Chun.

Transplants for the elderly in myeloma

Elevated Plasma Von Willebrand Factor and Decreased ADAMTS13 Antigen Levels in Patients with Immune Thrombocytopenia (ITP)‏ by Charlotte Louise Godfrey,

An Interim Analysis Of a Phase 2, Single-Arm Study Of Platelet Responses and Remission Rates In Patients With Immune Thrombocytopenia (ITP) Receiving Romiplostim.

FNAIT: the fetus pleads guilty!

Does treatment with intermittent infusions of intravenous anti-D allow a proportion of adults with recently diagnosed immune thrombocytopenic purpura to.

by Petri Salven, Lasse Teerenhovi, and Heikki Joensuu

A population-based study of cardiac morbidity among Hodgkin lymphoma patients with preexisting heart disease by Sten Myrehaug, Melania Pintilie, Lingsong.

Inherited DDX41 mutations: 11 genes and counting

What is a true ALCL? by Wolfram Klapper Blood Volume 124(9):

Hemoglobin levels in African-Americans

Clinical importance of ADAMTS13 activity during remission in patients with acquired thrombotic thrombocytopenic purpura by Evaren E. Page, Johanna A. Kremer.

Treatment of hypogammaglobulinemia in adults: A scoring system to guide decisions on immunoglobulin replacement Shradha Agarwal, MD, Charlotte Cunningham-Rundles,

In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activation by Bethan Psaila, James B. Bussel, Matthew.

Deep mining of the RBC proteome

Acute promyelocytic leukemia, microgranular variant

How we choose factor VIII to treat hemophilia

by Ernest Beutler Blood Volume 98(9): November 1, 2001

An actuarial GPS for hemophilic longevity

Taking a leaf from the book of oral tolerance

by Sabah Sallah, and Jim Y. Wan

Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response by Fotios P. Panitsas, Maria Theodoropoulou,

by Robert McMillan, Jennifer Lopez-Dee, and Joseph C. Loftus

ROCK and Rho(ll) in bone marrow

Blocking VWF platelet binding to treat TTP

by Tahereh Dadfarnia, and Stephen Lee

by Jon E. Arnason, Federico Campigotto, Donna Neuberg, and James B

Incidence and Predictors Of Venous Thromboembolism Among Lymphoma Patients In Denmark: A Nationwide Population-Based Cohort Study by Jennifer L Lund, Lene.

Treatment-related risk factors of inhibitor development in previously untreated patients with hemophilia A: the CANAL cohort study by Samantha C. Gouw,

by J. Evan Sadler Blood Volume 112(1):11-18 July 1, 2008

Does Helicobater pylori initiate or perpetuate immune thrombocytopenic purpura? by Marc Michel, Nichola Cooper, Christelle Jean, Christine Frissora, and.

Helicobacter pylori associated with idiopathic thrombocytopenic purpura Masaya Mukai, MD, PhD, Yujiro Kon, MD, Atsushi Notoya, MD, PhD, Michifumi Kohno,

Thymoma with idiopathic thrombocytopenic purpura: Report of a case

Platelet transfusions improve hemostasis and survival in a substudy of the prospective, randomized PROPPR trial by Jessica C. Cardenas, Xu Zhang, Erin.

by J. Michael Soucie, Paul E. Monahan, Roshni Kulkarni, Barbara A

Predicted number of joint bleeds according to factor activity level and age group for patients with hemophilia A or B based on a regression model. Predicted.

Post-bronchodilator forced expiratory volume in 1 s (FEV1) to forced vital capacity (FVC) ratio in subjects aged >50 yrs. Post-bronchodilator forced expiratory.

Ontogeny of platelet function

Ruptured abdominal aortic aneurysm: A population-based study

Varicella-Zoster Virus Disease Is More Frequent after Cord Blood Than after Bone Marrow Transplantation Kristel Vandenbosch, Philippe Ovetchkine, Martin.

Unrelated Umbilical Cord Blood Transplantation Using a TBI/FLAG Conditioning Regimen for Adults with Hematologic Malignancies Masaya Okada, Yoshihiro.

by Wendy Lim, Sara K. Vesely, and James N. George

Thrombotic thrombocytopenic purpura: diagnostic criteria, clinical features, and long-term outcomes from 1995 through 2015 by Evaren E. Page, Johanna A.

Time-dependent survival estimation in post–polycythemia vera myelofibrosis. Time-dependent survival estimation in post–polycythemia vera myelofibrosis.

A binding relationship with thrombin

Initial treatment of CLL: integrating biology and functional status

How I treat immune thrombocytopenia: the choice between splenectomy or a medical therapy as a second-line treatment by Waleed Ghanima, Bertrand Godeau,

Therapy of adult ITP before splenectomy.

Thrombocytopenia in pregnancy

Cold agglutinin disease

Presentation transcript:

by Henrik Frederiksen, and Kai Schmidt The Incidence of Idiopathic Thrombocytopenic Purpura in Adults Increases With Age by Henrik Frederiksen, and Kai Schmidt Blood Volume 94(3):909-913 August 1, 1999 ©1999 by American Society of Hematology

ITP incidence rates according to age and sex. ITP incidence rates according to age and sex. The horizontal bars correspond to incidence rates using a platelet count cut-off point of 50 × 109/L. Henrik Frederiksen, and Kai Schmidt Blood 1999;94:909-913 ©1999 by American Society of Hematology

ITP incidence rates in 3 periods of the study. Henrik Frederiksen, and Kai Schmidt Blood 1999;94:909-913 ©1999 by American Society of Hematology